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Ocular masquerade syndrome due to intraocular
lymphoma - two forms of retinal pigment epithelium
involvement: case reports
Ocular masquerade syndrome was diagnosted in two patients with chronic
uveitis. The patients presented non-Hodgkin’s lymphoma as the final
diagnosis two forms of intraocular retinal pigment epithelium involvement
was seen. One case was flecks of the retinal pigment epithelium and another
case was a solid retinal pigment epithelium detachment. These unusual
presentations of non-Hodgkin’s lymphoma is an alert to all involved in
lymphoma care.
ABSTRACT
RELATOS DE CASOS
INTRODUCTION
Ocular masquerade syndrome (OMS) is a group of diseases that occurs
with ocular inflammation and is misdiagnosed as a chronic uveitis(1).
It was first described as a chronic case of conjunctivitis masquerading
conjunctival carcinoma(2). In the same year, a diffuse epibulbar squamous
cell epithelioma masquerade case was reported(3).
In fact, OMS is the most commonly used term to describe diseases
simulating a chronic uveitis(1).
The causes of OMS may be benign or malignant disorders(1).
Nonmalignant diseases include: intraocular foreign body, retinal deta-
chment, pigment dispersion syndrome, postoperative infections, postvac-
cination disorders and drug reaction (rifabutin, didanoside).
Malignant diseases include: intraocular lymphomas (non-Hodgkin’s lym-
phoma of central nervous system, systemic non-Hodgkin’s lymphoma metas-
tatic to the eye, Hodgkin’s lymphoma, leukemia, carcinoma metastastic to  the
eye (lung, renal, breast) uveal melanoma, childhood malignancies (retinoblas-
toma, leukemia, meduloepithelioma, juvenile xanthogranuloma), paraneo-
plastic syndromes (cancer-associated retinopathy, melanoma-associated re-
tinopathy,  bilateral diffuse uveal melanocytic proliferation).
Gass classification(4) of  lymphoma is subdivided as follows: 1) Hodgkin’s
lymphoma; 2) large-cell non-Hodgkin’s lymphoma; 3) neoplastic angio-
endotheliomatosis; 4) lymphocytic lymphoma; 5) Burkitt’s lymphoma; 6)
mycosis fungoides; 7) multiple myeloma; 8) lymphoid granulomatosis.
Large-cell non-Hodgkin’s lymphoma has two forms of intraocular invol-
vement(5). One form originates from outside the central nervous system with
metastasis to the eye and the other form arises from within the central
nervous system and eye and is usually referred to as primary central nervous
system lymphoma(6).
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Primary central nervous system lymphoma initially invol-
ves the eye. The incidence of this form is 0.3% per 100,000
person-years in the immunocompetent population and 4 to 5
per 1,000 person-years among AIDS patients(7-8). The inciden-
ce has tripled over the past 2 decades(9). It accounted for
approximately 1,000 people per year in the United States(10).
Ocular involvement at the time of the diagnosis is 15% to 25%.
An estimated 100 new cases occurred in the United States
over the past 3 years(11). The disease affects an older popula-
tion (the median age is in the 50 to 60-year). There is a slight
male predominance(12). Ocular involvement may precede the
disease in the brain, spinal cord and leptomeninges(6,11).
Two thirds of the patients had the undiagnosed disease in
the central nervous system at the time the ocular diagnosis
was established(13). The time between the onset of ocular
symptoms and central nervous system symptoms varied from
7 to 108 months (mean 29 months)(13).
It also appears that immunosuppression appears to be a
risk factor for the development of ocular lymphoma(14-15).
In a study(13), the disease appeared typically as an interme-
diate or posterior uveitis. The common sites of ocular involve-
ment are the vitreous, retina, retinal pigment epithelium (RPE)
and the optic nerve head or any combination of these sites(4).
Cranial magnetic resonance imaging and a lumbar punctu-
re should be performed in all patients suspected of having
intraocular lymphoma and, if no malignant cells are found, a
culture medium tissue from a three-port pars plana vitrectomy
is made(1,4). The vitreous specimens were processed as pre-
viously described(16-17).
The intravitreal cytokine level can be useful in the diagno-
sis of intraocular lymphoma(18). Interleukin-10 can be produ-
ced by lymphoma cells and levels of interleukin-10 are eleva-
ted in both the serum and vitreous of patients with intraocular
lymphoma(18).
Treatment of primary central nervous system non-Hodgkin’s
lymphoma is controversial(5). In patients with the disease limited
to the eye, the treatment can be limited to the eye or can also
be applied prophylactically to the central nervous system. In a
series of cases(19), 10 of 11 patients with lymphoma limited to
the eyes at initial diagnosis later developed the disease in the
central nervous system.
Isolated radiation therapy is currently less used as single
therapy(20). Its association with systemic chemotherapy is a good
option(21-22). Systemic chemotherapy(23-24), intrathecal(25) and in-
travitreal methotrexate(26-27), are also used in selected cases.
The objective of this paper is to present two cases of pa-
tients with intraocular non-Hodgkin’s lymphoma, each sho-
wing a different form of retinal pigment epithelium involvement.
METHODS
We evaluated two patients with idiopathic uveitis preceding
non-Hodgkin’s lymphoma. One patient presented a systemic form
of large-cell non-Hodgkin’s lymphoma (case 1) and the other
showed primary central nervous system lymphoma (case 2).
CASE REPORTS
Case 1
 A 56-year-old Caucasian woman noted blurring, dimness
of vision, and floaters in the right eye. Her visual acuity was
20/80 in the right eye and 20/25 in the left eye. There were
paracentral scotomas in the right eye on Amsler grid testing.
The anterior segment was normal in both eyes. The intraocular
pressure was 16 mmHg in the right eye end 12 mmHg in the left
eye. There were 2+ vitreous cells, in the right eye. In the equa-
torial and posterior fundus we noted grey-white sub-RPE flecks
in the right eye (Figure 1).
The left fundus was normal. Fluorescein angiography sho-
wed a pattern of early nonfluorescence on a background of
hyperfluorescence on the posterior and equatorial fundus
corresponding to the retinal flecks; there was evidence of
some staining of the level of RPE in some areas of  the fundus
(Figure 2).
Eight months after the intraocular diagnosis the patient
developed systemic lymphoma with enlargement of lymph
nodes on the neck in addition to a depressed lesion at the base
of the neck, lymphadenophaty of the right axilla and supracla-
vicular areas. Computed tomography revealed peritoneal mas-
ses. A diagnosis of systemic lymphoma was established by
biopsy. One year after the initial ocular findings the patient
died of central nervous system metastasis.
Case 2
 A 65-year-old Caucasian female complained of blurred
vision and dimness of vision in the right eye. Her visual acuity
was 20/400 in the right eye and 20/25 in the left eye. The anterior
Figure 1 - Multiple retinal pigment epithelium infiltrates of the lymphoma
tumors
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segment was normal in both eyes. The intraocular pressure was
12 mmHg in the right eye end 14 mmHg in the left eye. There
were 2+ vitreous cells in the right eye. Ocular fundus examina-
tion revealed multiple yellowish-tan, variable-sized and-shaped
detachments of the retinal pigment epithelium widely scattered
throughout in the posterior pole and the macula region on the
right eye
The left eye ocular fundus was normal. Fluorescein angio-
graphy (FA) of the patient’s right eye revealed first show
blocking early because of the mass of tumor cells beneath the
RPE. The blocking is especially apparent in the macula where
the mass appears to be thickest (Figure 4).
The blocking is of the choroidal fluorescence and because
the cells lie in front of the choroid. Then the FA shows late
leakage from breakdown of the outer blood retinal barrier,
again due to the infiltration of the tumor cells (Figure 5).
Fluorescein angiography of the left eye was normal.
Ultrasonography of the right eye shows a questionable
thickening of the mass beneath the RPE (Figure 6)
Ten months after the ocular diagnosis the patient was
diagnosed as having central nervous system lymphoma with
lumbar puncture revealing lymphoid cells.
A B
Figure 2 - Hyperfluorescence of the multiple lesions in the late phases
on fluorescein angiography
Figure 3 - Multiple solid retinal pigment epithelium detachments in the
posterior pole
Figure 4 - Fluorescein angiography first show blocking early because
of the mass of tumor cells beneath the RPE
Figure 5 - Fluorescein angiography shows late leakage from breakdown
of the outer blood retinal barrier due to the infiltration of the tumor cells
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DISCUSSION
Ocular masquerade syndrome was found in 5% of all of the
uveitis cases(28). Intraocular malignancy corresponded to 2.5%
of the uveitis cases and 48% of the uveitis masquerade syn-
drome, while intraocular lymphoma corresponded to 32.5% of
the malignancies causing masquerade syndrome.
 The ocular-central nervous system form of large-cell non-
Hodgkin’s lymphoma is more frequent than the systemic mani-
festation. The systemic form corresponds to 25% of the pa-
tients with large-cell non-Hodgkin’s lymphoma(4).
The lymphoma cells in the ocular-central nervous system
form of the disease appear to arise primarily in the vitreous and
in the sub-RPE space and only secondarily extend to the retina
and choroid(4,29). Patients show a wide variety of pictures that
may simulate many ocular disorders. They are usually in the
sixth to seventh decade of life(4,29).
Young adults and children are occasionally affected(30).
The ocular-CNS form of large-cell lymphoma most frequen-
tly masquerades as posterior uveitis in patients complaining
of floaters caused by the vitreous infiltration with lymphoma-
tous and inflammatory cells.
Most of the patients develop multiple fundus lesions,
which initially may be relatively flat and appear similar to
multifocal choroiditis or multiple evanescent white dot syn-
drome, but  typically enlarge to form solitary, sharply defined,
blister-like yellowish sub-RPE tumors that are usually suffi-
ciently characteristic to allow an accurate diagnosis(4,29,31).
The fine speckling of pigment on the surface of the amelanotic
subretinal mounds is the biomicroscopic clue to the sub-RPE
locations of the tumors, which may be confluent and massive
in size. Other descriptions include white lesion tumors that
may simulate acute retinitis(32) branch artery occlusion by
infiltration of the major retinal artery(33), hemorrhagic infarc-
tion of the retina simulating that seen in acute retinal necro-
sis(34), lymphomatous infiltration of the retrobulbar portion of
the optic nerve simulating retrobulbar neuritis or infiltration of
the optic nerve head simulating papilitis(35-38), iridocyclitis and
secondary glaucoma(4).
In some patients there is a remarkable tendency of subpig-
ment epithelial lesions to resolve spontaneously. When this
occurs, early multifocal small scars simulating those in the
presumed ocular histoplamosis syndrome appear(39).
When large lesions resolve, large foci of geographic atro-
phy of the pigment epithelium may simulate that seen in dege-
nerative or postinflammatory disorders. It was published(4),
that when present, the multiple solid RPE masses are very
suggestive of large-cell lymphoma. It so happened in our case
2 when the patient presented multiple RPE solid detachment
predating central nervous system symptom involvement.
In the systemic form of large-cell non-Hodgkin’s lymphoma
the eye and brain are infrequently affected. When the eye is
involved, the lymphomatous infiltration occurs primarily in the
cilliary body and choroid. Choroid or sub-RPE infiltration may
produce a peculiar fundus picture composed of a reticular
pattern of yellowish-white flecks simulating fundus flavima-
culatus and serous detachment of the retina in the macular area;
this fundus picture may be confined only to the eye or may be
the presenting manifestation of the systemic lymphoma(4).
Our case 1 presented peculiar yellowish-white retinal pig-
ment epithelium flecks in the systemic large-cell non-Hodgkin’s
lymphoma. Eight months after the intraocular diagnosis the
patient developed systemic lymphoma with enlargement of
lymph nodes in the neck in addition to a depressed lesion at the
base of the neck. The patient subsequently died from complica-
tions of central nervous system involvement.
One patient was observed to have a systemic lymphoma
with this peculiar fundus picture in one eye and with multiple
large RPE tumors in his opposite eye typical of that in the
ocular-CNS form of large-cell non-Hodgkin’s lymphoma(4).
This observation suggests that there is some overlap in the
two forms of large-cell non-Hodgkin’s lymphoma(4,20).
A group of researchers from the National Eye Institute in
the United States(40) published different fluorescein angiogra-
phic patterns confirmed by histopathologic analysis. The
most common pattern were disturbances at the RPE level oc-
curring in 31 eyes from 17 patients with primary intraocular
lymphoma. These disturbances of the RPE were: granularity
(61%); blockage (55%) and late staining (45%), more than one
could be found in the same patient. Our cases had neither
characteristics. In this research RPE detachment and punctate
hyperfluorescent lesions were less common. These clinical
pictures should be recognized so that the diagnosis of lym-
phoma may be made as early as possible.
A practical clinical classification of intraocular lymphoid
tumors and infiltrations has been described(41) and further
studies will be necessary to show us if such classification will
lead to an appropriate baseline staging evaluation and impro-
ve our treatment of diseases of this category.
Figure 6 - Ultrasonography shows a questionable thickening of the
mass beneath the RPE
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RESUMO
Os autores apresentam dois casos de pacientes com  linfoma
não-Hodgkin, diagnosticados inicialmente como uveite crô-
nica de etiologia não determinada. Os exames posteriores a
partir da presença de outros sinais e sintomas demonstraram a
presença de linfoma não-Hodgkin nestes pacientes. Um dos
pacientes apresentava “flecks” ao nível do epitélio pigmentar
da retina e o outro paciente apresentava descolamento sólido
do epitélio pigmentar da retina. Estas formas de envolvimento
do epitélio pigmentar da retina não são usuais em linfoma não-
Hodgkin.
Descritores: Linfoma não-Hodgkin; Uveítes; Síndrome; Neo-
plasias do sistema nervoso central; Angiofluoresceinografia/
métodos; Epitélio pigmentado ocular; Relatos de casos [tipo
de publicação]
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